Diffusion Pharmaceuticals Inc. (44)

Browse by Contract Category

Contracts

Agreement, dated as of December 15, 2022, by and among Diffusion Pharmaceuticals Inc, LifeSci Special Opportunities Master Fund Ltd., LifeSci Special Opportunities Partners L.P.,... (Filed With SEC on December 16, 2022)
Employment Agreement, effective May 18, 2022, by and between the Company and Raven Jaeger, M.S (Filed With SEC on June 28, 2022)
Form of Subscription Agreement between Diffusion Pharmaceuticals Inc. and the investors named therein, dated March 18, 2022 (Filed With SEC on March 18, 2022)
Engagement Letter, dated March 27, 2020, by and between the Company and H.C. Wainwright & Co. LLC (Filed With SEC on May 20, 2020)
At-The-Market Sales Agreement, dated July 22, 2022, by and between Diffusion Pharmaceuticals Inc. and BTIG, LLC (Filed With SEC on July 22, 2022)
Form of Director RSU Agreement under 2015 Equity Incentive Plan (Filed With SEC on March 18, 2022)
Form of Stock Option Award Agreement under 2015 Equity Incentive Plan (Filed With SEC on March 18, 2022)
Amended & Restated Underwriting Agreement, dated February 11, 2021, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 18, 2021)
Form of Underwriter Warrant (Filed With SEC on February 18, 2021)
Employment Agreement, dated as of October 19, 2020, by and between Diffusion Pharmaceuticals Inc. and Christopher D. Galloway (Filed With SEC on October 20, 2020)
Employment Agreement, dated as of September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William R. Elder (Filed With SEC on September 25, 2020)
Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis (Filed With SEC on September 9, 2020)
Employment Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D (Filed With SEC on September 9, 2020)
Form of Securities Purchase Agreement, dated May 18, 2020, by and among the Company and the purchasers party thereto (Filed With SEC on May 20, 2020)
Form of Warrant (Filed With SEC on May 20, 2020)
Form of Placement Agent Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)
Form of New Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)
Warrant Exercise Agreement, dated May 6, 2020, by and between Diffusion Pharmaceuticals Inc. and the purchaser thereto (Filed With SEC on May 8, 2020)
Consulting Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
Description of Securities (Filed With SEC on March 17, 2020)
Engagement Letter, dated December 11, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on December 13, 2019)
Form of Securities Purchase Agreement, dated December 11, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on December 13, 2019)
Form of Placement Agent Warrant (Filed With SEC on December 13, 2019)
Form of Warrant (Filed With SEC on December 13, 2019)
Form of Series I Warrant (Filed With SEC on November 13, 2019)
Form of Series II Warrant (Filed With SEC on November 13, 2019)
Form of Wainwright Warrant (Filed With SEC on November 13, 2019)
Securities Purchase Agreement (Filed With SEC on November 13, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 13, 2019)
Form of Securities Purchase Agreement (Filed With SEC on November 8, 2019)
Engagement Letter, dated October 7, 2019, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 8, 2019)
Form of Placement Agents Warrant (Filed With SEC on November 8, 2019)
Form of Underwriters Warrant (Filed With SEC on November 8, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 8, 2019)
Form of Common Warrant (Filed With SEC on November 8, 2019)
Form of Underwriters Warrant (Filed With SEC on October 28, 2019)
Form of Pre-Funded Warrant (Filed With SEC on October 28, 2019)
Form of Common Warrant (Filed With SEC on October 28, 2019)
Form of Underwriting Agreement, dated [_______], by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on October 28, 2019)
Form of Placement Agent Warrant (Filed With SEC on May 28, 2019)
Engagement Letter, dated May 3, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 28, 2019)
Form of Securities Purchase Agreement, dated May 23, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on May 28, 2019)
Form of Warrant (Filed With SEC on May 28, 2019)